Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data GlobeNewswire - Tue Oct 22, 6:50AM CDT

BCT.TO : 1.24 (+11.71%)
BCTXW : 0.2906 (-3.04%)
BCTX : 0.8722 (+9.02%)
Biotech Advances Gain Momentum Amid October’s Rising Breast Cancer Rates and Awareness Efforts BayStreet.ca - Tue Oct 15, 8:31AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Each October, breast cancer awareness gains momentum through impactful campaigns and advancements in...

ONCY : 1.2700 (+0.79%)
PCSA : 1.3400 (-4.96%)
JAGX : 1.1700 (-0.85%)
BCTX : 0.8722 (+9.02%)
ONC.TO : 1.75 (-0.57%)
RHHBY : 39.1900 (-0.53%)
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study GlobeNewswire - Tue Oct 15, 6:50AM CDT

BCT.TO : 1.24 (+11.71%)
BCTXW : 0.2906 (-3.04%)
BCTX : 0.8722 (+9.02%)
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023 FinancialNewsMedia - Wed Sep 13, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 13, 2023 – USA News Group  –  Sufferers of many different ailments saw reason to grow their hope in 2022 when...

ONCY : 1.2700 (+0.79%)
ONC.TO : 1.75 (-0.57%)
FULC : 3.39 (-3.42%)
RNA : 47.38 (+1.43%)
BCTX : 0.8722 (+9.02%)
BCT.TO : 1.24 (+11.71%)
GILD : 88.16 (+2.17%)
Stocks in play: BriaCell Therapeutics Corp. Baystreet - Tue Jun 27, 2023

Announced that it has received approval from FDA on its pivotal registrational study design for Bria-IMT™ ...

BCTX : 0.8722 (+9.02%)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer BayStreet.ca - Tue Jun 27, 2023

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 909.15 (+0.33%)
PBYI : 2.84 (+1.07%)
GILD : 88.16 (+2.17%)
IMGN : 31.23 (unch)
BCTX : 0.8722 (+9.02%)
BCT.TO : 1.24 (+11.71%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer BayStreet.ca - Thu May 25, 2023

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 909.15 (+0.33%)
PBYI : 2.84 (+1.07%)
GILD : 88.16 (+2.17%)
IMGN : 31.23 (unch)
BCTX : 0.8722 (+9.02%)
BCT.TO : 1.24 (+11.71%)
Five Impressive Metastatic Cancer Treatment Stocks to Own Today BayStreet.ca - Mon May 15, 2023

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone...

LLY : 909.15 (+0.33%)
PBYI : 2.84 (+1.07%)
GILD : 88.16 (+2.17%)
IMGN : 31.23 (unch)
BCTX : 0.8722 (+9.02%)
BCT.TO : 1.24 (+11.71%)
Positive Developments for Breast Cancer Care Attracting Big Investor Attention BayStreet.ca - Mon Apr 17, 2023

A significant medical breakthrough is sorely needed in the fight against breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of invasive...

BCTX : 0.8722 (+9.02%)
PFE : 28.84 (-0.31%)
GILD : 88.16 (+2.17%)
PBYI : 2.84 (+1.07%)
MRK : 106.64 (+0.28%)
BCT.TO : 1.24 (+11.71%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer FinancialNewsMedia - Fri Mar 24, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new...

BCTX : 0.8722 (+9.02%)
ONCY : 1.2700 (+0.79%)
ONC.TO : 1.75 (-0.57%)
CTMX : 1.1000 (-5.17%)
BCT.TO : 1.24 (+11.71%)
RLAY : 6.66 (+3.58%)
HOLX : 81.58 (+0.53%)

Barchart Exclusives

2 Dividend Aristocrats to Buy Hand Over Fist as Markets Price in a Trump Presidency Barchart - Tue Oct 22, 6:30PM CDT
Some analysts believe that stock markets are pricing a Trump victory in the upcoming U.S. presidential elections. Nucor and ExxonMobil look like two Dividend Aristocrats to buy for investors looking to bet on a second Trump presidency. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot